BEAM 301 Shows Early Human Metabolic Correction
Beam reported initial Phase I/II human data for liver-directed base editing in glycogen storage disease type Ia on 27 October. Two of three patients in the 40 mg cohort reached the protocol’s 15-hour controlled-fasting…
